profile

Premium Stock Alerts

I'm a entrepreneur, author, and marketer who loves to talk about business & entrepreneurship, finance, and marketing & branding. Subscribe and join over 5,000+ newsletter readers every week!

Featured Post

2 Pharma Stocks Analysts Say Are Strong Buys

Issue #28 One fighting the opioid crisis, the other mastering biosimilars each could deliver powerful returns in the next 12 months. The healthcare sector is entering a new growth cycle—driven by innovation, cost efficiency, and a global push toward accessible treatment. From specialty drugs reshaping addiction therapy to generics powering affordability, two very different paths are defining the next era of pharma. As we move toward 2026, investors face a familiar question: is the smarter bet...

Issue #28 One global premium powerhouse. One deep-value turnaround play. Both could climb higher than you think. The outdoor gear market is shifting fast—from premium lifestyle brands that dominate global shelves to niche players fighting for a turnaround. Inflation, tariffs, and changing consumer habits have separated the winners from those just trying to stay on the trail. As we head into the final stretch of 2025, investors are asking one question: is it better to back proven profit...

Issue #28 Are You Missing Out? ZIP & UPWK Are Trading at a 20% Discount Hiring is in a strange place: budgets are tight, full-time roles are scarce, and yet the work keeps piling up. That’s creating two very different plays for investors. Upwork (NASDAQ: UPWK) is leaning into an AI-powered, on-demand talent model that lets companies scale work without headcount bloat. ZipRecruiter (NYSE: ZIP) is a high-beta bet on the U.S. hiring cycle—when the “Great Freeze” thaws, job postings and paid...

Issue #28 One’s drilling for growth - other’s fueling Brazil’s energy revival As oil prices stabilize and global energy demand strengthens, two small-cap energy names under $5 are positioning themselves for outsized gains. One is a nimble U.S. shale producer leveraging partnerships to ramp up output. The other is a Brazilian downstream giant executing a disciplined growth plan backed by dividends and infrastructure investments. 👉 Looking for a debt-free U.S. oil play with explosive upside? 👉...

Issue #28 The $5 Stock Duo We're Watching Right Now (Before Earnings Surge) 🏁 As Q4 earnings season heats up, two small-cap stocks under $5 are quietly building momentum—and could be ready to surprise the market. On one side, Emerald Holding (NYSE: EEX) is staging a comeback in live B2B events, turning post-pandemic recovery into real revenue growth. On the other, Zedge (AMEX: ZDGE) is transforming from a ringtone relic into a profitable AI-driven content platform built for the creator...

Issue #28 One just launched an FDA-approved cancer drug. The other could cure Rett syndrome. As biotech momentum accelerates, two breakthrough companies are defining the sector’s next phase of growth. On one side, Nuvation Bio (NYSE: NUVB) is evolving from a clinical-stage name into a commercial oncology powerhouse, riding the success of its newly approved cancer drug. On the other, Taysha Gene Therapies (NASDAQ: TSHA) is chasing a potential cure for Rett syndrome with full FDA alignment and...

Issue #28 From Wall Street’s trading floors to Africa’s mobile wallets, these companies are redefining the future of finance. 💸 As global markets shift gears, two fintech powerhouses are charting very different—but equally compelling—paths to growth. On one side, Interactive Brokers Group (NASDAQ: IBKR) is thriving in a high-rate world, turning client cash into record profits and redefining efficiency with AI-driven trading tools. On the other, DLocal Limited (NASDAQ: DLO) is capturing the...

Issue #28 Investing in Pet Parents: 2 Stocks Tapping America’s $140B Pet Obsession As the pet care industry evolves, a new divide is emerging between premium growth and survival mode. On one side, Freshpet (NASDAQ: FRPT) is redefining what pet food can be—fresh, refrigerated, and profitable. On the other, Petco (NASDAQ: WOOF) is fighting to reinvent itself from a traditional retailer into a modern health and wellness platform for pets. For investors, this isn’t just about loving pets—it’s...

Issue #28 📈 Both profitable, both expanding fast and both critical to every AI workload. As the AI boom accelerates, the spotlight has shifted to the infrastructure that powers it—memory, bandwidth, and data speed. Every AI model, from ChatGPT to enterprise data engines, depends on lightning-fast chips and controllers to process and store data efficiently. That’s where the next wave of opportunity lies. 👉 Looking for exposure to the hardware backbone of the AI revolution? 👉 Want profitable,...

Issue #28 Behind Every AI Conversation: These Two Stocks Are Winning While the market’s attention remains fixed on front-end AI companies, two behind-the-scenes innovators—Agora (NASDAQ: API) and The Glimpse Group (NASDAQ: VRAR)—are quietly building the infrastructure that makes real-time, immersive digital interaction possible. Agora delivers the invisible backbone for global voice, video, and interactive streaming. After several tough years of restructuring, the company just turned...